Close Menu

NYGC

The site, introduced at the American Society of Human Genetics meeting last week, supports genotyping data generated by 23andMe, AncestryDNA, and FamilyTreeDNA.

The repository will provide phenotypic, proteomic, metabolomic, genomic datasets, treatment protocols, and more from, potentially, 10,000 autism patients and families.

The New York Genome Center will sequence genomes of patients who died of ALS and who have donated tissue samples to Target ALS.

The Journal of the American Medical Association catches up with Harold Varmus on the next stage of his career.

The NYGC is currently preparing to submit a number of additional clinical tests to the state including assays for cancer and constitutional disorders.

Varmus plans to establish a "modestly sized" research laboratory at the Meyer Cancer Center at Weill-Cornell Medical College and to assist the New York Genome Center.

Thirteen institutions and life sciences companies have teamed up to launch the free repository that will offer access to allele frequency information from genomes and exomes.

Douglas Sites has joined Rosetta Genomics as its executive VP of sales and marketing, a newly created position. Sites will report to Kenneth Berlin, president and CEO of the company.

Lucigen has hired David Theil as senior vice president and CFO.

NEW YORK (GenomeWeb) — The New York Genome Center's new clinical laboratory has obtained a permit from the New York State Department of Health and is preparing to submit its first clinical sequencing test — an exome test for inherited disorders — to the state this month, Clinical Sequencing N

Pages

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.